Short Interest in Kuraray Co. (OTCMKTS:KURRY) Increases By 50.0%

Key Points

• Kuraray Co. experienced a 50% increase in short interest from mid-August to the end of August, totaling 300 shares.
• The stock has a market capitalization of $3.85 billion and trades mostly around $35, with a 52-week high of $47.28.
• In its latest quarterly earnings, Kuraray reported $1.42 billion in revenue, with earnings per share at $0.04 and a net margin of 1.90%.

Kuraray Co. (OTCMKTS:KURRY - Get Free Report) was the target of a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 300 shares, an increase of 50.0% from the August 15th total of 200 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is presently 1.5 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 200 shares, the days-to-cover ratio is presently 1.5 days.

Kuraray Price Performance

KURRY stock traded down $1.08 during trading on Friday, hitting $34.55. 346 shares of the stock traded hands, compared to its average volume of 202. The stock has a market cap of $3.74 billion, a price-to-earnings ratio of 35.25 and a beta of 0.08. Kuraray has a one year low of $30.01 and a one year high of $47.28. The company has a current ratio of 2.44, a quick ratio of 1.33 and a debt-to-equity ratio of 0.22. The company has a 50 day simple moving average of $35.43 and a 200 day simple moving average of $35.85.

Kuraray (OTCMKTS:KURRY - Get Free Report) last posted its quarterly earnings data on Friday, August 8th. The company reported $0.04 earnings per share for the quarter. The company had revenue of $1.42 billion during the quarter. Kuraray had a net margin of 1.90% and a return on equity of 5.38%.

Kuraray Company Profile

Kuraray Co, Ltd. engages in the production and sale of resins, chemicals, fibers, activated carbon, and high-performance membranes and systems worldwide. The Vinyl Acetate segment manufactures and markets functional resins and films, including PVA, PVB and EVAL. The Isoprene segment engages in the manufacture and marketing of SEPTON thermoplastic elastomer, isoprene-related products, and GENESTAR.